| Therapeutic Area | Indication | Target | Stage | Partner |
|---|---|---|---|---|
| Oncology | Solid tumors | AKAP-4 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Verik bio |
| Oncology | Pancreatic cancer | PI3K | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Land of Hessen |
| Oncology | Multiple oncology indications | MetAP2 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Cureteq |
| Oncology | Multiple oncology indications | OX40 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Cureteq |
| Oncology | Pancreatic cancer | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Oncology and Inflammatory diseases | Confidential | PIM family | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Inflection Biosciences |
| Immunology | Multiple immunology indications | IL-17 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Cureteq |
| Inflammatory disorders | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Inflammatory disorders | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Inflammatory disorders | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Discoveric bio alpha |
| Mental health disorders | Depression | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Anxiety | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Sleep disorder | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | ADHD | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Opoid abuse | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Schizophrenia | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Sensori-neural diseases | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Metabolic diseases | T1D and co-morbidities | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Cardiology | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Dermatology + others | Confidential | TLR | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Dermatology | Confidential | TLR | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Dermatology | Confidential | TLR | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Infectious diseases | Antimicrobial resistance | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Discoveric bio beta |
| Infectious diseases | Covid-19 | 3CLPro | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Land of Hessen |
| Pain related indications | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| ICU treatment | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Rare diseases | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Rare diseases | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Multiple TAs | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read More
